DOCSLIB.ORG

Guide to Infection Prevention and Control in Personal Service Settings, 3Rd Edition

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Guide to Infection Prevention and Control in Personal Service Settings, 3rd edition First Revision: July 2019 Public Health Ontario Public Health Ontario is a Crown corporation dedicated to protecting and promoting the health of all Ontarians and reducing inequities in health. Public Health Ontario links public health practitioners, frontline health workers and researchers to the best scientific intelligence and knowledge from around the world. Public Health Ontario provides expert scientific and technical support to government, local public health units and health care providers relating to the following: communicable and infectious diseases infection prevention and control environmental and occupational health emergency preparedness health promotion, chronic disease and injury prevention public health laboratory services Public Health Ontario's work also includes surveillance, epidemiology, research, professional development and knowledge services. For more information, visit publichealthontario.ca. How to cite this document: Ontario Agency for Health Protection and Promotion (Public Health Ontario). Guide to infection prevention and control in personal service settings. 3rd ed., 1st revision. Toronto, ON: Queen’s Printer for Ontario; 2019. ©Queen’s Printer for Ontario, 2019 Public Health Ontario acknowledges the financial support of the Ontario Government. Previously published as: Ontario. Ministry of Health and Long-Term Care. Infection prevention and control best practices for personal services settings. 2nd ed. Toronto, ON: Queen’s Printer for Ontario; 2009. Publication history: 1st edition: 1998 (Ministry of Health and Long-term Care) 2nd edition: 2009 (Ministry of Health and Long-term Care) 3rd edition: November 2018 1st Revision: July 2019 Guide to Infection Prevention and Control in Personal Service Settings i Summary of Revisions First published: November 2018 The evidence in this document is current to November, 2018. Changes in this revision are summarized in the table below. Summary of changes in 1st revision: Date of Implementation Description of Major Changes Page(s) Removed requirement for single-use disposable blades to be Jun-19 97 sterile (e.g., shaving razors, callus blades) Reclassification of level of reprocessing required for reusable 100, 103, Jun-19 handles/holders for blades (e.g., scalpels, shaving razors, 104 callus blades) Guide to Infection Prevention and Control in Personal Service Settings ii Acknowledgements We gratefully acknowledge the assistance of the following organizations and individuals in updating and reviewing the 2018 A Guide to Infection Prevention and Control in Personal Service Settings. Public Health Ontario Sandra Callery Sam MacFarlane Director, Program IPAC Specialist, Infection Prevention and Control Infection Prevention and Control Claudine D’Souza Emily Nadolny Nurse Consultant, Research Coordinator, Infection Prevention and Control Infection Prevention and Control Laura Farrell Pat Piaskowski Program IPAC Specialist, Specialist/Writer, Infection Prevention and Control Infection Prevention and Control Isabelle Guerreiro David Ryding Program IPAC Specialist, Program IPAC Specialist, Infection Prevention and Control Infection Prevention and Control Colin MacDougall Grace Volkening Research Coordinator, Program IPAC Specialist, Infection Prevention and Control Infection Prevention and Control Ministry of Health and Long-Term Care Caroline Marshall Duri Song Strategy and Policy Advisor, Policy Analyst, Infectious Disease Policy and Programs Infectious Disease Policy and Programs Danielle Reimer Janu Sritharan Programs and Policy Advisor, Senior Policy and Program Advisor, Infectious Infectious Disease Policy and Programs Infectious Disease Policy and Programs Public Health Units Cecilia Alterman Christian Lapensee Manager Control of Infectious Public Health Inspector, Diseases/Infection Control, Ottawa Public Health Toronto Public Health Katherine Mayer Public Health Inspector, Simcoe Muskoka District Health Unit Guide to Infection Prevention and Control in Personal Service Settings iii Christina Milani Joanne Ristov Public Health Inspector, Public Health Inspector, Grey Bruce Health Unit Wellington-Dufferin-Guelph Public Health Roxana Nassiri Annie Seto-Choo Public Health Inspector, Public Health Inspector, Huron County Health Unit York Region Public Health Selina Nazim Jenee Wallace Manager Infection Prevention and Control, Public Health Inspector, York Region Public Health Simcoe Muskoka District Health Unit Katherine Paphitis Public Health Inspector, Wellington-Dufferin-Guelph Public Health The following Public Health Ontario staff also contributed to the development of this document: Helen Bedkowski Brandy Kirchen Manager Programs and Resources, Network Assistant, Infection Prevention and Control Infection Prevention and Control Barbara Catt Mabel Lim Manager IPAC Response and System Support, Infection Prevention and Control Specialist, Infection Prevention and Control Infection Prevention and Control Donna Moore Dr. Maureen Cividino Infectious Disease Physician, Infection Prevention and Control Specialist, Infection Prevention and Control Infection Prevention and Control Tim Cronsberry Francine Paquette Infection Prevention and Control Specialist, Manager IPAC Regional Support, Infection Prevention and Control Infection Prevention and Control Danijela Draganic Lori Schatzler Product Development Specialist, Infection Prevention and Control Specialist, Infection Prevention and Control Infection Prevention and Control Marianne Walker Dr. Gary Garber Chief, Network Assistant, Infection Prevention and Control Infection Prevention and Control Julie Hui-Chih Wu Lucia Zdeb Research Coordinator, Senior Communication Advisor, Knowledge Services Infection Prevention and Control Guide to Infection Prevention and Control in Personal Service Settings iv Disclaimer This document was developed by Public Health Ontario (PHO). PHO provides scientific and technical advice to Ontario’s government, public health organizations and health care providers. PHO’s work is guided by the current best available evidence at the time of publication. The application and use of this document is the responsibility of the user. PHO assumes no liability resulting from any such application or use. This document may be reproduced without permission for non-commercial purposes only and provided that appropriate credit is given to PHO. No changes and/or modifications may be made to this document without express written permission from PHO. Guide to Infection Prevention and Control in Personal Service Settings iv Contents Preamble ....................................................................................................................................................... 1 About This Document ............................................................................................................................... 1 IPAC Practices in PSS ................................................................................................................................. 2 1. Chain of Transmission ........................................................................................................................... 3 1.1 Infectious Agent ............................................................................................................................ 4 1.2 Reservoir ....................................................................................................................................... 5 1.3 Portal of Exit .................................................................................................................................. 5 1.4 Mode of Transmission ................................................................................................................... 5 1.4.1 Contact Transmission ................................................................................................................. 5 1.4.2 Droplet Transmission ................................................................................................................. 7 1.4.3 Vehicle-Borne Transmission ....................................................................................................... 7 1.5 Portal of Entry ............................................................................................................................... 8 1.6 Susceptible Host ............................................................................................................................ 8 2. Routine Practices .................................................................................................................................. 9 2.1 Risk Assessment ............................................................................................................................ 9 2.2 Hand Hygiene .............................................................................................................................. 10 2.2.1 Hand Rubbing Using ABHR ....................................................................................................... 11 2.2.2 Hand Washing Using Soap and Water ..................................................................................... 12 2.2.3 Other Hand Hygiene Products.................................................................................................. 13 2.2.4 Hand Care ................................................................................................................................
Recommended publications
  • The Jewellery Market in the Eu

    The Jewellery Market in the Eu

    CBI MARKET SURVEY: THE JEWELLERY MARKET IN THE EU CBI MARKET SURVEY THE JEWELLERY MARKET IN THE EU Publication date: September 2008 CONTENTS REPORT SUMMARY 2 INTRODUCTION 5 1 CONSUMPTION 6 2 PRODUCTION 18 3 TRADE CHANNELS FOR MARKET ENTRY 23 4 TRADE: IMPORTS AND EXPORTS 32 5 PRICE DEVELOPMENTS 44 6 MARKET ACCESS REQUIREMENTS 48 7 OPPORTUNITY OR THREAT? 51 APPENDICES A PRODUCT CHARACTERISTICS 53 B INTRODUCTION TO THE EU MARKET 56 C LIST OF DEVELOPING COUNTRIES 57 This survey was compiled for CBI by Searce Disclaimer CBI market information tools: http://www.cbi.eu/disclaimer Source: CBI Market Information Database • URL: www.cbi.eu • Contact: [email protected] • www.cbi.eu/disclaimer Page 1 of 58 CBI MARKET SURVEY: THE JEWELLERY MARKET IN THE EU Report summary This survey profiles the EU market for precious jewellery and costume jewellery. The precious jewellery market includes jewellery pieces made of gold, platinum or silver all of which can be in plain form or with (semi-) precious gemstones, diamonds or pearls. The costume jewellery market includes imitation jewellery pieces of base metal plain or with semi-precious stones, glass, beads or crystals. It also includes imitation jewellery of any other material, cuff links and hair accessories. This survey excludes second-hand jewellery and luxury goods such as gold and silver smith’s ware (tableware, toilet ware, smokers’ requisites etc.) and watches. Consumption Being the second largest jewellery market after the USA, the EU represented 20% of the world jewellery market in 2007. EU consumers spent € 23,955 million with Italy, UK, France and Germany making up the lion’s share (70%).
  • COVID-19 in Ontario: Focus on April 4, 2021 to April 10, 2021

    COVID-19 in Ontario: Focus on April 4, 2021 to April 10, 2021

    Weekly Epidemiologic Summary COVID-19 in Ontario: Focus on April 4, 2021 to April 10, 2021 This report includes the most current information available from CCM as of April 13, 2021. Please visit the interactive Ontario COVID-19 Data Tool to explore recent COVID-19 data by public health unit, age group, sex, and trends over time. A daily summary is available and provides an epidemiologic summary of recent COVID-19 activity in Ontario. This weekly report provides an epidemiologic summary of COVID-19 activity in Ontario over time. Highlights There are a total of 389, 169 confirmed cases of COVID-19 in Ontario with a public health unit reported date up to April 10, 2021. For the period with a public health unit reported date between April 4 to 10, 2021 (week 14): A total of 25,663 cases were reported to public health compared to 18,929 cases the previous week (March 28 to April 3, 2021). This represents the largest number of cases reported in a single week (n=25,663). The previous peak occurred in week 1 (January 3 to 9, 2021; n=24,867) during the second wave of the pandemic. In waves one and two of the pandemic, people aged 80 and over had the highest rate of cases per 100,000 population among all age groups during the peaks (219.4 and 229.1, respectively). During wave three, this age group has the lowest rate of disease (73.2) while cases aged 20-39 are reporting the highest rate (233.3). The term public health unit reported date in this document refers to the date local public health units were first notified of the case.
  • Mapping the Municipal Planning Process in Ontario

    Mapping the Municipal Planning Process in Ontario

    MAPPING THE MUNICIPAL PLANNING PROCESS IN ONTARIO Opportunities for Public Health Input About This report is the result of the Locally Driven Collaborative Project (LDCP) program, which brings Ontario Public Health Units together to conduct research on issues of shared interest related to the Ontario Public Health Standards. Study Team This LDCP project was led by Dr. Charles Gardner, Medical Officer of Health for the Simcoe Muskoka District Health Unit. Core team members: • Brenda Armstrong, Simcoe Muskoka District Health Unit • Steven Rebellato, Simcoe Muskoka District Health Unit • Brent Moloughney, Public Health Ontario • Ghazal Fazli, Public Health Ontario • Rachel Harris, Public Health Ontario • Charoula Tsamis, Public Health Ontario • Tiffany Lee, Public Health Ontario Co-applicant members: • Sue Shikaze, Haliburton, Kawartha, Pine Ridge District Health Unit • Karen Loney, Chatham-Kent Public Health Unit • Birgit Isernhagen, Ottawa Public Health • Donald Cole, Dalla Lana School of Public Health, University of Toronto • Helen Doyle, Ontario Public Health Association • Ahalya Mahendra, Public Health Agency of Canada Clean Air Partnership consultant team was led by Nancy Smith Lea, Director, The Centre for Active Transportation. Consultant team members: • Jiya Benni, Researcher, The Centre for Active Transportation • Windemere Jarvis, Public Health Specialist • Francis Nasca, Project Manager, The Centre for Active Transportation • Thrmiga Sathiyamoorthy, Public Health Specialist • Yvonne Verlinden, Project Manager, The Centre for Active
  • Ethical Conduct Uniform Attire and Personal Appearance

    Ethical Conduct Uniform Attire and Personal Appearance

    Ethical Conduct, Uniform Attire and Personal Appearance Policy for Nurses and Midwives Office of the Deputy Prime Minister Ministry for Health HEALTHCARE SERVICES DIRECTORATE Ethical Conduct, Uniform Attire and Personal Appearance Policy for Nurses and Midwives. Title Ethical Conduct, Uniform Attire and Personal Appearance Policy for Nurses and Midwives. Summary This document provides instruction as well as guidance about the standards of proper dress code and personal appearance required for all the Nursing and Midwifery staff working in all the different entities within the Public Health Sector. Responsible Director Director Nursing Services Issue Date April 2018 Review Date April 2020 Reviewed and agreed The Nursing Services Directorate in upon by collaboration with the Nursing and Midwifery Management, Practice Nurses Infection Control and the MUMN. Related Policies and SOP : ICU 003 Standard Operating Guidelines: Procedure for proper Dress code and Traffic within Operating Theatres No Smoking Policy Hra02POL2007v02.6 Policy No: ICU _ 05 POL2011v01- Bare Below the Elbows Policy Hand Hygiene Policy. ICU_02 POL2009 v01.0 Public Service Commission (Disciplinary Procedure) Regulations, 1999. OPM No 21/2015. Policy on the use of Social Media in the Public Service. Nurses and Midwives guide to Social Media. Nursing Services Directorate 2016. 1 2 1. Policy Summary The personal appearance and attire of the Nursing and Midwifery professionals can impact on the safety provided to clients as well as the public perception of the quality of services provided and professionalism at large. Therefore all nursing and midwifery personnel working with patients/clients and/or patients’/clients’ families or/and in public areas are expected to dress in a professional manner.
  • Evidence Brief: Foraged Mushroom Consumption in Ontario  Wild Mushrooms Are Found in Ontario’S Farmers’ Markets

    Evidence Brief: Foraged Mushroom Consumption in Ontario  Wild Mushrooms Are Found in Ontario’S Farmers’ Markets

    EVIDENCE BRIEF Foraged Mushroom Consumption in Ontario November 2019 Key Messages Wild mushrooms are widespread in Ontario, and are harvested by individual hobbyists and commercial enterprises for public consumption. Many species are poisonous. Health effects of such species can range from mild to severe, including death. However, serious poisonings are rare. There are no simple tests to determine if a mushroom is poisonous. Safe consumption of wild mushrooms and other wild foods requires they be correctly identified by knowledgeable harvesters. Over a thousand calls were made to the Ontario Poison Centre (OPC) over a recent 5-year period that were mushroom-related, with at least 90 cases resulting in hospital admission. There are no reported cases of poisoning linked to commercial foraging. However, currently there is no mechanism for licensing or accrediting wild mushroom foragers. Evidence Brief: Foraged Mushroom Consumption in Ontario Wild mushrooms are found in Ontario’s farmers’ markets. Certain farmers’ market food vendors are exempt from the Food Premises Regulation. However, assessments and inspections may be carried out to ensure compliance with the Health Protection and Promotion Act. Issue and Research Question Foraging of wild mushrooms occurs in diverse communities, including some within Ontario. 1-3 Foraged mushrooms may be sold in farmers’ markets, grocery stores, health food stores, restaurants, and online. There are reported cases of adverse health outcomes from consuming foraged mushrooms.1 Public health units in Ontario have requested advice from Public Health Ontario in response to concerns of potential adverse health effects from consumption of wild foraged mushrooms being sold in their regions.
  • Exhibit 2 Crown-Controlled Corporations

    Exhibit 2 Crown-Controlled Corporations

    Exhibit 2 Crown-Controlled Corporations Corporations whose accounts are audited by an auditor other than the Auditor General, with full access by the Auditor General to audit reports, working papers and other related documents as required Alcohol and Gaming Commission of Ontario North West Local Health Integration Network Agricultural Research Institute of Ontario Ontario Capital Growth Corporation Central East Local Health Integration Network Ontario College of Trades Central Local Health Integration Network Ontario French-language Educational Central West Local Health Integration Network Communications Authority (TFO) Champlain Local Health Intgration Network Ontario Health Quality Council Education Quality and Accountability Office Ontario Infrastructure and Lands Corporation eHealth Ontario (Infrastructure Ontario) Erie St. Clair Local Health Integration Network Ontario Lottery and Gaming Corporation Forest Renewal Trust Ontario Pension Board (Dec 31)* General Real Estate Portfolio Ontario Power Generation Inc. (Dec 31)* Hamilton Niagara Haldimand Brant Local Health Ontario Tourism Marketing Partnership Corporation Integration Network Ontario Trillium Foundation HealthForceOntario Marketing and Recruitment Ottawa Convention Centre Corporation Agency Owen Sound Transportation Company Limited Health Shared Services Ontario (HSSOntario) Ontario Agency for Health Protection and Higher Education Quality Council of Ontario Promotion (Public Health Ontario) Human Rights Legal Support Centre Royal Ontario Museum Hydro One Inc. (Dec 31)* Science
  • Declaration in Stone Tokens

    Declaration in Stone Tokens

    Declaration In Stone Tokens Steward is unexclusive and drug ropily while interjacent Zalman bruted and diamond. Which Dave arrests so downright that Wilhelm boggled her Nehru? Is Town fuggy or stirred when trapes some Justina factorise unwarrantably? Maeda tells her are a bus anywhere you control deals damage to access, which you in stone Grand lodges developed within them in stone? Perhaps a stone manland mtg wiki is often hot dog ownership. Card with that your library until your relationship where the city residents local, proclaiming a promise rings are temporarily spawn an. Wholesale Jewelry Direct Distributor is efficient direct importer, wholesaler, carry sterling silver jewerly, costume fashion jewelry, swimwear swimsuits, fashion apparel clothing sarong, body piercing jewellery, gifts, watches Serving USA Canada international. Oyo to launch hotel business in Japan. Declaration We doesn't Collect Any user Personal Information In Our Application. Honor their exceptional jewelry sets, though traditionally maori carvers produced stunning view all new brews for you have some casinos, logic and sorcery speed spell queller, declaration in stone tokens! Michael has meaning behind the end of the truth, lodges that probably one of pendant necklaces and generates a month. In a sworn court declaration filed in August 2017 Ching wrote that he happened. We can guarantee card in stone. Shogi also became as Japanese chess or watching Game of Generals is more two-player strategy board. Participate in stone manland mtg wiki is life symbol of stones including the mana of the most people and my love you enjoy telegram channels. James: If I were writing a love even today to paw, it always say enormous I loved you before I fall you.
  • Confirmed Cases of COVID-19 Following Vaccination in Ontario

    Confirmed Cases of COVID-19 Following Vaccination in Ontario

    ENHANCED EPIDEMIOLOGICAL SUMMARY Confirmed Cases of COVID-19 Following Vaccination in Ontario: December 14, 2020 to September 18, 2021 Purpose This report describes confirmed cases of coronavirus disease 2019 (COVID-19) following COVID-19 vaccination. In order to identify cases with a symptom onset date after receipt of vaccine (i.e. post-vaccination cases), vaccine uptake data extracted from the Ontario Ministry of Health’s (MOH) COVaxON application was linked to case data extracted from the MOH’s Public Health Case and Contact Management Solution (CCM). Further details on the linkage are described in the Technical Notes. Data in this report include the most current information extracted from COVaxON as of September 20, 2021 at approximately 7:00 a.m. and CCM as of September 20, 2021 at 1:00 p.m. The report includes COVID-19 vaccinations and cases reported up to September 18, 2021. For additional information on COVID-19 vaccine uptake in the province, please visit the interactive Ontario COVID-19 Data Tool to explore vaccination uptake data by public health unit, age group and trends over time. The weekly report on COVID-19 Vaccine Uptake and Program Impact in Ontario further describes vaccine uptake across the province as well as the impact of the vaccination program on COVID-19 cases and severe outcomes. Background This report provides a focused analysis on confirmed cases of COVID-19 infection following COVID-19 vaccination. While vaccines provide a high degree of protection from COVID-19 infection, it is expected that a small proportion of vaccinated individuals may become infected as no vaccine is 100% effective.
  • IPAC Recommendations for Use of Personal Protective Equipment for Care of Individuals with Suspect Or Confirmed COVID‑19

    IPAC Recommendations for Use of Personal Protective Equipment for Care of Individuals with Suspect Or Confirmed COVID‑19

    TECHNICAL BRIEF IPAC Recommendations for Use of Personal Protective Equipment for Care of Individuals with Suspect or Confirmed COVID‑19 6th Revision: May 2021 Introduction This document summarizes recommendations for infection prevention and control (IPAC) best practices for use of personal protective equipment (PPE) in health care settings. The document was updated to reflect the best available evidence at the time of writing. Updates to the document are noted in the Summary of Revisions. Please note that the Ministry of Health's Directive 5 is the provincial baseline standard for provision of personal protective equipment for hospitals, long-term care homes and retirement homes during COVID-19.1 Key Findings The primary mode of SARS-CoV-2 transmission is at short range through unprotected close contact and exposure to respiratory particles that range in size from large droplets, which fall quickly to the ground, to smaller droplets, also known as aerosols, which can remain suspended in the air. Outbreak case studies describe long-range transmission under the right set of favourable conditions (e.g., prolonged exposure in crowded, poorly ventilated spaces), implicating aerosols in transmission. Several studies demonstrate the effectiveness of current Infection Prevention and Control (IPAC) practices and personal protective equipment (PPE) when applied appropriately and consistently. Droplet and Contact Precautions continue to be recommended for the routine care of patients* with suspected or confirmed COVID‑19. Airborne Precautions should be used for aerosol generating medical procedures (AGMPs) planned or anticipated to be performed on patients with suspected or confirmed COVID‑19. Fully immunized staff should continue to use Droplet and Contact Precautions when caring for patients with suspected or confirmed COVID-19.
  • 2018 Statistical Report

    2018 Statistical Report

    2018 STATISTICAL REPORT Office of the Information and Privacy Commissioner of Ontario Privacy and Accountability for a Digital Ontario CONTENTS 1 Requests by the Public under FIPPA/MFIPPA 2 Provincial Compliance 10 Municipal Compliance 26 Summary of Appeals — 2018 vs. 2017 36 Judicial Reviews 39 Summary of Privacy Complaints — 2018 vs. 2017 42 Requests by the Public under PHIPA 43 Compliance 60 Summary of PHIPA Complaints — 2018 vs. 2017 63 Reported Privacy Breaches under PHIPA ACCESS Requests by the Public under FIPPA/MFIPPA There were 58,812 freedom of information requests filed across Ontario in 2018, a two per cent decrease over 2017 when 59,807 were filed. TOTAL FOI REQUESTS FILED BY JURISDICTION AND RECORDS TYPE Personal General Information Records Total Municipal 18,670 16,434 35,104 Provincial 8,221 15,487 23,708 Total 26,891 31,921 58,812 TOTAL FOI REQUESTS COMPLETED BY JURISDICTION AND RECORDS TYPE Personal General Information Records Total Municipal 18,487 16,160 34,647 Provincial 7,810 16,206 24,016 Total 26,297 32,366 58,663 TOTAL FOI REQUESTS COMPLETED BY SOURCE AND JURISDICTION Source Municipal Provincial Total Individual/Public 21,160 4,485 25,645 Individual by Agent 7,698 5,698 13,396 Business 3,336 12,094 15,430 Academic/Researcher 137 130 267 Association/Group 439 422 861 Media 587 682 1,269 Government (all levels) 739 324 1,063 Other 551 181 732 Total Requests 34,647 24,016 58,663 OUTCOME OF REQUESTS BY JURISDICTION Source Municipal Provincial Total All Information Disclosed 8,328 5,626 13,954 Information Disclosed
  • COVID-19 in Ontario: January 15, 2020 to March 31, 2021

    COVID-19 in Ontario: January 15, 2020 to March 31, 2021

    Daily Epidemiologic Summary COVID-19 in Ontario: January 15, 2020 to March 31, 2021 This report includes the most current information available from CCM as of March 31, 2021. Please visit the interactive Ontario COVID-19 Data Tool to explore recent COVID-19 data by public health unit, age group, sex, and trends over time. A weekly summary report is available with additional information to complement the daily report. This daily report provides an epidemiologic summary of recent COVID-19 activity in Ontario. The change in cases is determined by taking the cumulative difference between the current day and the previous day. Highlights There are a total of 352,460 confirmed cases of COVID-19 in Ontario reported to date. Compared to the previous day, this represents: An increase of 2,557 confirmed cases (percent change of +9.6%) An increase of 23 deaths (percent change of +53.3%) An increase of 1,814 resolved cases (percent change of -8.1%) In this document, the term ‘change in cases’ refers to cases publicly reported by the province for a given day. Data corrections or updates can result in case records being removed and or updated from past reports and may result in subset totals for updated case counts (i.e., age group, gender) differing from the overall updated case counts. The term public health unit reported date in this document refers to the date local public health units were first notified of the case. COVID-19 in Ontario: January 15, 2020 to March 31, 2021 1 Case Characteristics Table 1a.
  • Um 1897, Testimony & Exhibits, 2/12/2018

    Um 1897, Testimony & Exhibits, 2/12/2018

    BEFORE THE PUBLIC UTILITY COMMISSION OF OREGON UM 1897 In the Matter of ) ) HYDRO ONE LIMITED, ) ) Application for Authorization to Exercise ) Substantial Influence over Policies and ) Actions of AVISTA CORPORATION. ) ) REPLY TESTIMONY OF THE OREGON CITIZENS’ UTILITY BOARD February 12th, 2018 Table of Contents Introduction ....................................................................................................................................2 Background of Hydro One ...........................................................................................................4 Risks ..............................................................................................................................................7 Political Risk ................................................................................................................................7 North American Free Trade Agreement Risk ............................................................................14 Post-Transaction Corporate Structure ........................................................................................17 Double Leverage Holding Company ..........................................................................................19 Why Avista .................................................................................................................................24 Benefits ..........................................................................................................................................27 Exhibits